Takeda Pharmaceutical
316 hedge funds and large institutions have $2.45B invested in Takeda Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 100 increasing their positions, 98 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
316
Holders Change
-30
Holders Change %
-8.67%
% of All Funds
6.94%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
33
Increased
100
Reduced
98
Closed
61
Calls
$78.2M
Puts
$81.2M
Net Calls
-$3.01M
Net Calls Change
-$19.4M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$26.4M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
+$20.2M |
| 3 |
AC
Adelphi Capital
London,
United Kingdom
|
+$18.2M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$17.4M |
| 5 |
Renaissance Technologies
New York
|
+$16M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$36.2M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$34.6M |
| 3 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$26.1M |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$15.8M |
| 5 |
Morgan Stanley
New York
|
-$15.2M |
